Wei Xia Ang

Title: Wei Xia Ang: Innovator in Tumor Immunology

Introduction

Wei Xia Ang is a prominent inventor based in Singapore, known for his contributions to the field of tumor immunology. He has developed innovative methods that enhance the effectiveness of immune cells in targeting cancer cells. His work is crucial in advancing cancer treatment methodologies.

Latest Patents

Wei Xia Ang holds a patent for "Gamma delta T cells and a method of augmenting the tumoricidal activity of the same." This invention relates to a method of generating γδ T cells that have at least one down-regulated co-inhibitory receptor. The method involves culturing a population of cells comprising γδ T cells with a phosphoantigen to expand these cells. Additionally, the expanded γδ T cells are cultured with artificial antigen-presenting cells expressing a Fc receptor and an anti-CD3 antibody. This patent represents a significant advancement in the generation of γδ T cells and their medical applications.

Career Highlights

Wei Xia Ang is affiliated with the Agency for Science, Technology and Research, where he conducts research and development in immunology. His work has led to significant advancements in understanding how to manipulate immune responses for therapeutic purposes.

Collaborations

He collaborates with notable colleagues such as Shu Wang and Jieming Zeng, contributing to a dynamic research environment that fosters innovation in cancer treatment.

Conclusion

Wei Xia Ang's contributions to the field of tumor immunology through his innovative patent and collaborative efforts highlight his role as a key figure in advancing cancer therapies. His work continues to inspire future research in this critical area of medicine.